Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: SIX Swiss Ex
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Roche Holding AG

+ Add to Watchlist

ROG:VX

247.000 CHF 1.000 0.41%

As of 11:43:58 ET on 05/17/2013.

Company Profile for Roche Holding AG (ROG)

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Contact Information

Roche Holding AG

Grenzacherstrasse 124
Basel, 4070
Switzerland
Phone: 41-61-688-1111
Fax: 41-61-691-9391

Key Executives for Roche Holding AG (ROG)

Franz B HumerChairmanSeverin SchwanChief Executive Officer
Alan HippeChief Financial OfficerUrs JaisliChief Compliance Officer
Roland DiggelmannCOO:Roche DiagnosticsDaniel OdayCOO:Roche Pharmaceuticals
Per-Olof AttingerSecretaryGottlieb A KellerGeneral Counsel
Luke MielsHead:Asia-PacificStephan FeldhausHead:Group Communications
Silvia AyyoubiHead:Human ResourcesKarl MahlerHead:Investor Relations
Richard H SchellerHead:Genentech Research & Early DevSophie Kornowski-BonnetHead:Partnering

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil